Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)

9.81
Delayed Data
As of Feb 12
 +0.33 / +3.48%
Today’s Change
1.38
Today|||52-Week Range
55.75
-21.39%
Year-to-Date
No recent news for Aquinox Pharmaceuticals Inc.

Today’s Trading

Previous close9.48
Today’s open9.49
Day’s range9.30 - 10.00
Volume245,837
Average volume (3 months)289,756
Market cap$168.8M
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)-216.09%
Earnings growth (this year)+36.22%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.90

Competitors

 Today’s
change
Today’s
% change
CYNACynapsus Therapeutic...+0.41+3.13%
CRHMCRH Medical Corp-0.01-0.41%
--China Health Group I...+0.02+11.87%
AGRXAgile Therapeutics I...+0.25+4.16%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 14, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$0.00
Annual profit (last year)-$23.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
David J. Main
Chief Financial Officer &
Vice President
Kamran Alam
Corporate headquarters
Vancouver, British Columbia

Forecasts

Partner Offers